Endovenous Laser Therapy (EVLT) for Sapheno-Popliteal Incompetence and Short Saphenous Vein (SSV) Reflux: A RCT

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00841178
Recruitment Status : Unknown
Verified December 2014 by Daniel Carradice, University of Hull.
Recruitment status was:  Active, not recruiting
First Posted : February 11, 2009
Last Update Posted : December 3, 2014
Hull and East Yorkshire Hospitals NHS Trust
Information provided by (Responsible Party):
Daniel Carradice, University of Hull

Brief Summary:

Varicose veins are a common problem, affecting up to a third of the western adult population. Most suffer with aching, discomfort, pruritis, and muscle cramps, whilst complications include oedema, eczema, lipodermatosclerosis, ulceration, phlebitis, and bleeding. This is known to have a significant negative effect on patient's quality of life (QoL).

Surgery has been used for many years, but it is known that there is a temporary decline in QoL post-op. This was demonstrated in our pilot study. Surgery leads to painful and prolonged recovery in some patients and has the risks of infection, haematoma and nerve injury.

Recurrence rates are known to be significant. Duplex of veins post surgery has demonstrated persistent reflux in 9-29% of cases at 1 year, 13-40% at 2 years, 40% at 5 years and 60% at 34 years.

26% of NHS patients were 'very dissatisfied' with their varicose vein surgery.

Newer, less invasive treatments are being developed. It would be advantageous to find a treatment that avoided the morbidity of surgery, one that could be performed as a day-case procedure under a local anaesthetic, a treatment that could offer lower recurrence rates and allow an early return to work. These should be the aims of any new treatment for varicose veins.

Endovenous Laser Treatment (EVLT) is performed under a local anaesthetic and uses laser energy delivered into the vein to obliterate it. The vein therefore need not be tied off surgically and stripped out.

The aim of this study is to compare the clinical, cost effectiveness and safety of Surgery and EVLT.

Condition or disease Intervention/treatment
Venous Insufficiency Varicose Veins Procedure: Surgery Procedure: EVLT

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 106 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomised Controlled Trial of the Clinical and Cost Effectiveness of Endovenous Laser Therapy in the Treatment of Varicose Veins Secondary to Isolated Sapheno-Popliteal Incompetence and Short Saphenous Reflux
Study Start Date : October 2005
Primary Completion Date : August 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: GERD Varicose Veins
U.S. FDA Resources

Arm Intervention/treatment
Active Comparator: Surgery
Patients undergo Surgery under a general anaesthetic.
Procedure: Surgery
Saphenopopliteal junction ligation, stripping of the Short Saphenous vein where possible, perforator ligation and ambulatory phlebectomy, where necessary.
Other Name: Crossectomy
Experimental: EVLT
Patients undergo EVLT under a local anaesthetic.
Procedure: EVLT
EVLT of the Short saphenous vein with perforator ligation and / or ambulatory phlebectomy as required.
Other Name: Endovenous Laser therapy, Endovenous Laser Ablation, EVLA

Primary Outcome Measures :
  1. Generic Quality of Life - Short Form-36 [ Time Frame: 1 Week,, 6 Weeks, 3 Months, 1 Year, 2 Years ]

Secondary Outcome Measures :
  1. Disease Specific Quality of Life - Aberdeen Varicose Vein Questionnaire [ Time Frame: 1 Week, 6 Weeks, 3 Months, 1 Year, 2 Years ]
  2. Generic quality of life - EuroQol [ Time Frame: 1 week, 6 weeks, 3 months, 1 year, 2 years ]
  3. Venous Clinical Severity Score [ Time Frame: 3 months, 1 year, 2 years ]
  4. Visual analogue pain scores [ Time Frame: 1 week ]
  5. Return to work and normal functioning [ Time Frame: 1 week, 6 weeks ]
  6. Would undergo EVLT again if necessary [ Time Frame: 1 week, 6 weeks, 3 months, 1 year, 2 years ]
  7. Complication rates [ Time Frame: 1 week, 6 weeks, 3 months, 1 year, 2 years ]
  8. Duplex assessment [ Time Frame: 1 week, 6 weeks, 3 months, 1 year, 2 years ]
  9. Cost Effectiveness [ Time Frame: 2 years ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Primary, symptomatic, varicose veins
  • Isolated Sapheno-popliteal (SPJ) incompetence, leading to reflux in the Short saphenous vein (SSV) on duplex ultrasound
  • SSV of 4mm distally
  • Ability to give informed written consent

Exclusion Criteria:

  • Inability to give informed written consent
  • Symptomatic or complicated varicose veins not attributable to SPJ/SSV reflux
  • Evidence of deep venous reflux on duplex scan

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00841178

United Kingdom
Hull Royal Infirmary
Hull, East Yorkshire, United Kingdom, HU3 2JZ
Sponsors and Collaborators
University of Hull
Hull and East Yorkshire Hospitals NHS Trust
Principal Investigator: Ian C Chetter, MBChB University of Hull

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Daniel Carradice, Clinical Lecturer, University of Hull Identifier: NCT00841178     History of Changes
Other Study ID Numbers: HELP 2
First Posted: February 11, 2009    Key Record Dates
Last Update Posted: December 3, 2014
Last Verified: December 2014

Keywords provided by Daniel Carradice, University of Hull:
Randomised controlled trial
Venous insufficiency
Varicose veins
Quality of Life
Clinical effectiveness
Cost effectiveness

Additional relevant MeSH terms:
Venous Insufficiency
Varicose Veins
Vascular Diseases
Cardiovascular Diseases